Joint Commission launches Medication Compounding Certification
Editor's Note
The Joint Commission on February 21 launched a Medication Compounding Certification that addresses new medication compounding laws and regulations.
The certification, which is awarded for a 2-year period, was developed in collaboration with the United States Pharmacopeial Convention (USP) to help healthcare organizations ensure compliance with Joint Commission and USP standards, including those related to the process, testing, and verification of compounded sterile and nonsterile preparations.
View the multimedia news release Across the United States, patient safety and quality events related to medication compounding have led many state legislatures and boards of pharmacy to enhance and strengthen regulations. To support health care organizations in complying with these requirements, The Joint Commission has developed a new Medication Compounding Certification program.
Read More >>
Free Daily News
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities
- Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
- FDA Class 1 recall renews concern about historically problematic heart pumps
- New physician compensation report reveals modest pay gains but growing discontent with the profession
- Surge in corporate ownership of medical practices raises concerns over physician autonomy, care quality
- How Minneapolis healthcare real estate remained strong amid challenges, shifts in patient care preferences: Lessons for other states
- Artificial intelligence (AI) captures uncertainty in medical scans